Published in
Elsevier, European Journal of Cancer, (109), p. 84-91, 2019
DOI: 10.1016/j.ejca.2018.11.014
Links
Tools
A phase I/II trial of olaparib tablet in combination with eribulin in Japanese patients with advanced or metastatic triple-negative breast cancer previously treated with anthracyclines and taxanes
Journal article published in 2019 by
Kan Yonemori 
,
Akihiko Shimomura,
Hiroyuki Yasojima,
Norikazu Masuda,
Kenjiro Aogi,
Masato Takahashi,
Yoichi Naito,
Satoru Shimizu,
Rikiya Nakamura,
Jun Hashimoto,
Harukaze Yamamoto,
Akihiro Hirakawa,
Hirofumi Michimae,
Akinobu Hamada,
Teruhiko Yoshida
and other authors.
,
Akihiko Shimomura,
Hiroyuki Yasojima,
Norikazu Masuda,
Kenjiro Aogi,
Masato Takahashi,
Yoichi Naito,
Satoru Shimizu,
Rikiya Nakamura,
Jun Hashimoto,
Harukaze Yamamoto,
Akihiro Hirakawa,
Hirofumi Michimae,
Akinobu Hamada,
Teruhiko Yoshida
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 